These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21138207)

  • 1. Closing the gaps: the impact of inpatient detoxification and continuity of care on client outcomes.
    Ford LK; Zarate P
    J Psychoactive Drugs; 2010 Sep; Suppl 6():303-14. PubMed ID: 21138207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of patients in a VA ambulatory detoxification program.
    Wiseman EJ; Henderson KL; Briggs MJ
    Psychiatr Serv; 1997 Feb; 48(2):200-3. PubMed ID: 9021850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agency-level financial incentives and electronic reminders to improve continuity of care after discharge from residential treatment and detoxification.
    Acevedo A; Lee MT; Garnick DW; Horgan CM; Ritter GA; Panas L; Campbell K; Bean-Mortinson J
    Drug Alcohol Depend; 2018 Feb; 183():192-200. PubMed ID: 29288914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage to Primary Care for Persons First Receiving Injectable Naltrexone During Inpatient Opioid Detoxification.
    Stein MD; Risi MM; Bailey GL; Anderson BJ
    J Subst Abuse Treat; 2016 May; 64():44-6. PubMed ID: 26920817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing Behavioral Health Inpatient Readmissions for People With Substance Use Disorders: Do Follow-Up Services Matter?
    Reif S; Acevedo A; Garnick DW; Fullerton CA
    Psychiatr Serv; 2017 Aug; 68(8):810-818. PubMed ID: 28412900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Agency Receipt of Incentives and Reminders on Engagement and Continuity of Care for Clients With Co-Occurring Disorders.
    Lee MT; Acevedo A; Garnick DW; Horgan CM; Panas L; Ritter GA; Campbell KM
    Psychiatr Serv; 2018 Jul; 69(7):804-811. PubMed ID: 29695226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Validity of Outpatient Follow-up After Detoxification as a Quality Measure.
    Schmidt EM; Gupta S; Bowe T; Ellerbe LS; Phelps TE; Finney JW; Humphreys K; Trafton J; Vanneman ME; Harris AHS
    J Addict Med; 2017; 11(3):205-210. PubMed ID: 28282324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admissions to detoxification after treatment: Does engagement make a difference?
    Acevedo A; Garnick D; Ritter G; Lundgren L; Horgan C
    Subst Abus; 2016; 37(2):364-71. PubMed ID: 26308604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost Savings from a Navigator Intervention for Repeat Detoxification Clients.
    Hodgkin D; Brolin MF; Ritter GA; Torres ME; Merrick EL; Horgan CM; Hopwood JC; De Marco N; Gewirtz A
    J Ment Health Policy Econ; 2019 Mar; 22(1):3-13. PubMed ID: 30991351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of enhanced telephone monitoring with detoxification patients: 3- and 6-month outcomes.
    Timko C; Below M; Vittorio L; Taylor E; Chang G; Lash S; Festin FED; Brief D
    J Subst Abuse Treat; 2019 Apr; 99():24-31. PubMed ID: 30797391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of treatment outcomes: lifetime depression versus the continuum of care.
    Miller NS; Ninonuevo F; Hoffmann NG; Astrachan BM
    Am J Addict; 1999; 8(3):243-53. PubMed ID: 10506905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug abuse treatment outcome study of adolescents: a comparison of client characteristics and pretreatment behaviors in three treatment modalities.
    Rounds-Bryant JL; Kristiansen PL; Hubbard RL
    Am J Drug Alcohol Abuse; 1999 Nov; 25(4):573-91. PubMed ID: 10548436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aftercare plans of inpatients undergoing detoxification.
    Tuten M; Jones HE; Lertch EW; Stitzer ML
    Am J Drug Alcohol Abuse; 2007; 33(4):547-55. PubMed ID: 17668340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer completion rates and treatment modality.
    Radinsky TL
    J Community Psychol; 1976 Jul; 4(3):239-45. PubMed ID: 10243941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Unplanned Early Discharges from a Dual Diagnosis Inpatient Detoxification Unit in Israel.
    Sofer MM; Kaptsan A; Anson J
    J Dual Diagn; 2018; 14(3):137-147. PubMed ID: 29668421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.